Fatty acid profile of the erythrocyte membranes of healthy Bahraini citizens in comparison with coronary heart disease patients

Journal of Oleo Science

Volumn 58, Issue 7, 2009, Pages 379-388

  Freije, Afnan ^a  

^a UNIVERSITY OF BAHRAIN   (Bahrain)

Author keywords

CHD; DHA; EPA; Fatty acids; Omega 3; Red blood cells

Indexed keywords

EID: 67649766715     PISSN: 13458957     EISSN: 13473352     Source Type: Journal    
DOI: 10.5650/jos.58.379     Document Type: Article

References (58)

1. Simopoulos, A.P. Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins Leukot. Essent. Fatty Acids. 60, 421-429 (1999).
2. Simopoulos, A.P.; Ordovas, J. Nutrigenetics and nutrigenomics. World rev. Nutr. Diet. 93, Basel: Karger (2004).
3. Paganelli, F.; Maixent, J.M.; Duran, M.J. Alteredery-throcyte n-3 fatty acids in Mediterranean patients with coronary artery disease. Inter. J. Cardio. 78, 27-32 (2001).
4. Rupp, H.; Wagner, D.; Rupp, T.; Schulte, L.M.; Maisch, B. Risk stratification by the EPA+DHA Level and the EPA/AA Ratio focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids. Herz. 29, 673-685 (2004).
5. Harris, W.S.; Reid, K.J.; Sands, S.A.; Spertus, J.A. Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients. Am. J. Cardio. 99, 154-158 (2007).
6. Simopoulos, A.P.; Cleland, L.G. Omega-6/omega-3 essential fatty acid ratio: The scientific evidence. World Rev. Nutr. Diet. 92 Basel: Karger (2003).
7. Anil, E. The impact of EPA and DHA on blood lipids and lipoprotein metabolism: Influence of apoE geno-type. Proceed. Nutr. Soci. 66, 60-68 (2007).
8. Din, J.N.; Newby, D.E.; Flapan, A.D. Omega-3 fatty acids and cardiovascular disease-fishing for a natural treatment. Brit. Med. J. 328-330 (2004).
9. Jude, S.; Roger, S.; Martel, E.; Besson, P.; Bougnoux, S.R.P.; Champeroux, P.; Le Guennec, J.Y. Dietary long-chain omega-3 fatty acids of marine origin: A compari-son of their protective effects on coronary heart disease and breast cancers. Progress biophys. Molecul. Bio. 90, 299-325 (2006).
10. Rissanen, T.; Voutilainen, S.; Nyyssonen, K.; Lakka, T.A.; Salonen, J.T. Fish oil-derived fatty acids, docosa-hexanoic acid and docosapentanoic acid, and the risk of coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation 102, 2677-2679 (2000).
11. Albert, C.M.; Campos, H.; Stampfer, M.J.; Ridker, P.M.; Manson, J.E.; Willett, W.C.; Ma, J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. New Engl. J. Medic. 346, 1113-1118 (2002).
12. Lemaitre, R.N.; King, I.B.; Mozaffarian, D.; Kuller, L.H.; Tracy, R.P.; Siscovick, D.S. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: The Cardiovascular Health Study. Am. J. Clin. Nutr. 77, 319-325 (2003).
13. Hostmark, A.T.; Bjerkedal, A.; Kierulf, P.; Flaten, H.; Ulshagen, K. Fish oil and plasma fibrinogen. Brit. Med. J. 297, 180-181(1988).
14. Geleijnse, J.M.; Giltay, E.J.; Grobbee, D.E.; Donders, A.R.; Kok, F.J. Blood pressure response to fish oil supplementation: meta-regression analysis of randomized trials. J. Hypertension. 20, 1493-1499 (2002).
15. Harris, W.S.; von Schacky, C. The omega-3 index: a new risk factor for death from coronary heart disease? Prevent. Med. 39, 212-220 (2004).
16. Marchioli, R.; Barzi, F.; Bomba, E. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Preven-zione. Circulation 105, 1897-1903 (2002).
17. Van der Werf, F.; Ardissino, D.; Betriu, A.; Cokkinos, D.V.; Falk, E.; Fox, K.A. Management of acute myocar-dial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur. Heart J. 24, 28-66 (2003).
18. Ernahrung Gohlke, H.Z. Role of hormone-replacement therapy for prevention of coronary artery disease in women. Kardiol. 94, 22-29 (2005).
19. Smith, S.C.; Allen, J.; Blair, S.N.; Bonow, R.O.; Brass, L.M.; Fonarow, G.C. AHA/ACC guidelines for sec-ondary prevention for patients with coronary and other atherosclerotic vascular disease. Circulation 113, 2363-2372 (2006).
20. Rose, H.G.; Oklander, M. Improved procedure for the extraction of lipids from human erythrocytes. J. lipid Res. 6, 428-431 (1965).
21. Morrison, W.R.; Smith, L.M. Preperation of fatty acid methyl esters and dimethylacetates from lipids with boronfluoride-methanol. J. Lipid Res. 5, 600-608 (1964).
22. Reddy, R.D.; Keshavan, M.S.; Yao, J.K. Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline. Schizophrenia Bulletin 30, 901-911 (2004).
23. Vessby, B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr. Opin. Lipidology 14, 15-19 (2003).
24. Wijendran, V.; Hayes, K.C. Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Ann. Rev. Nutr. 24, 597-615 (2004).
25. Holub, D.J.; Holub, B.J. Omega-3 fatty acids from fish oils and cardiovascular disease. Molec. Cellu. Biochem. 263, 217-225 (2004).
26. Mori, T.A.; Beilin, L.J. Omega-3 fatty acids and inflam- mation. Curr. Atheroscler. Report 6, 461-467 (2004).
27. Rise, P.; Eligini, S.; Ghezzi, S.; Colli, S.; Galli, C. Fatty acid composition of plasma, blood cells and whole blood: Relevance for the assessment of the fatty acid status in humans. Prostaglandins Leukot. Essent. Fatty Acids 76, 363-369 (2007).
28. Stanford, J.L.; King, I.; Kristal, A.R. Long-term storage of red blood cells and dietary fatty acids: results from a pilot study. Nutr. Cancer 16, 183-188 (1991).
29. Das, U.N. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins Leukot. Essent. Fatty Acids 52, 387-391 (1995).
30. Nettleton, J.A.; Katz, R. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes; A review. J. Am. Diet Associ. 105, 428-440 (2005).
31. Das, U.N. A defect in the activity of delta-6 and delta-5 desaturases may be a factor in the initiation and progression of atherosclerosis. Prostaglandins Leukotr. Essential Fatty Acids 76, 251-268 (2007).
32. Vessby, B.; Gustafsson, I.B.; Tengbald, S.; Boberg, M.; Andersson, A. Desaturation and elongation of fatty acids and insulin action. Ann. New York Academy Sci. 967, 183-195 (2002).
33. Pereira, S.L.; Leonard, A.E.; Huang, Y.S.; Chuang, L.T.; Mukerji, P. Identification of two novel microalgal enzymes involved in the conversion of the w-3 fatty acid, eicosapentanoic acid, into docosahexanoic acid. Biochem. J. 384, 357-366 (2004).
34. Erkkila, A.; de Mello, V.D.F.; Riserus, U.; Laaksonen, D.E. Dietary fatty acids and cardiovascular disease: An epidemiological approach. Prog. Lipid Res. 47, 172-187 (2008).
35. Holman, R.T.; Johnson, S.B.; Gerrard, J.M.; Mauer, S.M.; Kupcho-Sandberg, S.; Brown, D.M. Arachidonic acid deficiency in streptozocin-induced diabetes. Proceed. Natl. Acad. Sci, USA 80, 2375-2379 (1983).
36. El Boustani, S.; Causse, J.E.; Descomps, B.; Monnier, L.; Mendy, F.; Crastes de Paules, A. Direct in vivo characterization of delta-5-desaturase activity in humans by deuterium labeling: Effect of insulin. Metabolism 38, 315-321 (1989).
37. Health Statistic Report. Ministry of Health, Kingdom of Bahrain for the year (2006).
38. McKeigue, P.M.; Shah, B.; Marmot, M.G. Relation of central obesity and insulin resistance with high dia-betes prevalence and cardiovascular risk in South Asians. Lancet 337, 382-386 (1991).
39. FAO/WHO. Report, fats and oils in human nutrition. Rome: Food and agricultural organization of the United Nations. 49-55 (1993).
40. The British Nutrition Foundation. Recommendations for intakes of unsaturated fatty acids. in The report of thee British Nutrition Foundation's task force. New York: Chapman and Hall. 152-163 (1992).
41. Horrocks, L.A.; Yeo, Y.K. Health benefits of docosahexanoic acid (DHA). Pharmacol. Res. 40, 3-18 (1999).
42. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E in 11,324 patients with myocardial infarction: Results of the GISSI-Prevenzione trial Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354, 447-455 (1999).
43. Wang, C.; Harris, W.S.; Chung, M.; Lichtenstein, A.H.; Balk, E.M.; Kupelnick, B.; Jordan, H.S.; J. Lau, J. n-3 Fatty acids from fish or fish-oil supplements, but not a-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary- prevention studies: a systematic review. Am. J. Clinical Nutr. 84, 5-17 (2006).
44. Jacobson, T.A. Secondary prevention of coronary artery disease with omega-3 fatty acids. Am. J. Cardio. 98, 61i-70i (2006).
45. Psota, T.L.; Gebauer, S.K.; P. Kris-Etherton, P. Dietary omega-3 fatty acid intake and cardiovascular risk. Am. J. Cardio. 98, 3i-18i (2006).
46. von Schacky, C.; Harris, W.C. Cardiovascular benefits of omega-3 fatty acids. Cardiovascu. Res. 73, 310-315 (2007).
47. Simopoulos, A.P. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed. Pharmacotherapy 60, pp. 502-507 (2006).
48. Mahaffey, K.R. Fish and shellfish as dietary sources of methylmercury and omega-3 fatty acids, eicosahexanoic acid and docosahexanoic acid: risks and benefits. Environ. Res. 95, 414-428 (2004).
49. Harris, W.S.; Gonzales, M.; Laney, N.; Sastre, A.; Borkon, A.M. Effects of Omega-3 fatty acids on heart rate in cardiac transplant recipients. Am. J. Cardio. 98, 1393-1395 (2006).
50. McNamara, R.K.; Carlson, S.E. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins, Leukotr. Essent. Fatty Acids 75, 329-349 (2006).
51. Pepe, S.; McLennan, P.L. Dietary fish oil confers direct antiarrhythmic properties on the myocardium of rats. J. Nutr. 126-134 (1996).
52. Al-Arrayed, F.H.; Al-Maskati, H.A.; Abdullah, F.J. n-3 Polyunsaturated fatty acid content of some edible fish from Bahrain waters. Estu. Coast. Shelf Sci. 49, 109-114 (1999).
53. USDA Nutrient Data Laboratory. http://www.nalusda.gov/fnic/foodcomp/. (Accessed November 2008).
54. Xu, X.Q.; Beardall, J. Effect of salinity on fatty acid composition of a green microalgae from Antarctic hypersaline lake. Phytochem. 45, 655-658 (1997).
55. Directorate of Fisheries. Annual Statistics report. Ministry of Commerce and Agriculture, Bahrain (2005).
56. Kris-Etherton, P.M.; Innis, S. Position of the American diabetic association and dieticians of Canada: Dietary fatty acids. J. Am. Dietetic Assoc. 107, 1599-1611 (2007).
57. Kris-Etherton, P.M.; Hill, A.M. n-3 Fatty acids or supplements? J. Am. Diabetic Asso. 108, 1125-1130 (2008).
58. Kris-Etherton, P.M.; Harris, W.; Appel, W. AHA Scientific Statement. Fish consumption, fish oil, omega-3 fatty acids and cardiovascular disease. Circulation 106, 2747-2757 (2002).